Pure Global
NCT06406010

Investigating the Effect of Pericapsular Nerve Group (PENG) Block on Postoperative Pain After Peri-acetabular Osteotomy

A Blinded Randomized Study Investigating the Effect of Pericapsular Nerve Group (PENG) Block on Postoperative Pain After Peri-acetabular Osteotomy
Matias Vested·Phase 4·ClinicalTrials.gov·drugNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Anesthesia, Local
Drug/Device/Intervention
Ropivacaine 5mg/ml 20ml
Study type
Interventional
Intervention type
drug
Sponsor & location
Primary sponsor
Matias Vested
Funder
Rigshospitalet, Denmark
Location
Copenhagen, Denmark
Timeline & enrollment
Phase
Phase 4
Start date
Jun 01, 2024
End date
Jan 01, 2026
Enrollment
90 participants
Primary outcome

Pain during first 24 hours postoperatively

Summary

The aim of this study is to determine the effect of PENG blockade on postoperative pain after
 either ropivacaine 5 mg/mL or saline (placebo) in patients undergoing PAO. The hypothesis of
 this study is that PENG block with ropivacaine reduces postoperative pain compared to placebo
 (saline).

ICD-10 classifications
Local anaestheticsAnaesthetic, unspecifiedOther and unspecified general anaestheticsPoisoning: Local anaestheticsParenteral anaesthetics
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06406010
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06406010 through Pure Global AI's free database. This Phase 4 trial is sponsored by Matias Vested and is currently Not yet recruiting. The study focuses on Anesthesia, Local. Target enrollment is 90 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.